813 related articles for article (PubMed ID: 19667990)
1. State of the art: implantable ventricular assist devices.
Lahpor JR
Curr Opin Organ Transplant; 2009 Oct; 14(5):554-9. PubMed ID: 19667990
[TBL] [Abstract][Full Text] [Related]
2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
3. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
[TBL] [Abstract][Full Text] [Related]
4. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
[TBL] [Abstract][Full Text] [Related]
5. Ventricular assist device support in children and adolescents as a bridge to heart transplantation.
Sharma MS; Webber SA; Morell VO; Gandhi SK; Wearden PD; Buchanan JR; Kormos RL
Ann Thorac Surg; 2006 Sep; 82(3):926-32. PubMed ID: 16928510
[TBL] [Abstract][Full Text] [Related]
6. Cardiac prosthesis as an advanced surgical therapy for end-stage cardiac patients: current status and future perspectives.
Takatani S
J Med Dent Sci; 2000 Sep; 47(3):151-65. PubMed ID: 12160228
[TBL] [Abstract][Full Text] [Related]
7. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
8. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.
Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F
J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965
[TBL] [Abstract][Full Text] [Related]
9. Cardiac extracorporeal life support: state of the art in 2007.
Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
[TBL] [Abstract][Full Text] [Related]
11. [Surgical therapy of end-stage heart failure. State of the art 2006].
Klotz S; Loeher A; Drees G; Scheld HH
Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064
[TBL] [Abstract][Full Text] [Related]
12. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances).
Kirklin JK; Holman WL
Curr Opin Cardiol; 2006 Mar; 21(2):120-6. PubMed ID: 16470148
[TBL] [Abstract][Full Text] [Related]
13. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
[TBL] [Abstract][Full Text] [Related]
14. Current axial-flow devices--the HeartMate II and Jarvik 2000 left ventricular assist devices.
John R
Semin Thorac Cardiovasc Surg; 2008; 20(3):264-72. PubMed ID: 19038737
[TBL] [Abstract][Full Text] [Related]
15. Axial flow blood pumps.
Song X; Throckmorton AL; Untaroiu A; Patel S; Allaire PE; Wood HG; Olsen DB
ASAIO J; 2003; 49(4):355-64. PubMed ID: 12918574
[TBL] [Abstract][Full Text] [Related]
16. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
[TBL] [Abstract][Full Text] [Related]
17. [The DeBakey VAD axial flow pump: first clinical experience with a new generation of implantable, nonpulsatile blood pumps for long-term support prior to transplantation].
Wieselthaler GM; Schima H; Lassnigg A; Pacher R; Ovsenk T; Laufer G; Noon GP; DeBakey ME; Wolner E
Wien Klin Wochenschr; 1999 Sep; 111(16):629-35. PubMed ID: 10510840
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular device as destination therapy: are we there yet?
Badiwala MV; Rao V
Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
[TBL] [Abstract][Full Text] [Related]
20. [Ventricular assist devices as bridge to heart transplantation in cardiogenic shock or terminal heart failure--12 years experience at the Sheba Medical Center].
Lavee J; Kassif Y; Freimark D; Har Zahav Y; Koman V; Preisman S; Smolinsky A; Raanani E
Harefuah; 2007 Nov; 146(11):833-6, 911. PubMed ID: 18087826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
